Intuitive Surgical, Inc.
ISRGNasdaqFull coverage
Latest dossier
AI-generated
General research and analysis by Moatsight, not personalized investment advice. We show, you decide. Disclaimers
Q3 of fiscal year 2026 · Published Nov 1, 2026,
Intuitive Surgical makes the da Vinci surgical robot and earns most of its revenue afterwards, from the instruments used in every operation and from service contracts, which made up 84% of revenue in the third quarter of 2026. Revenue grew 21.7% to $3.05 billion in the quarter, but worldwide da Vinci procedure growth slowed for the fourth quarter running, to about 14%, with the US at about 10%. The company plans to cut instrument revenue per procedure by about 3% to 5% from 2027 to widen adoption in cost-sensitive benign surgery, while new robots from Medtronic, Johnson & Johnson and Stryker reach the US market. Moatsight estimates revenue of about $13.1 billion over the next four quarters, with growth slowing through 2027.
What you pay
| Figure | At the close | 5-yr median | 5-yr range |
|---|---|---|---|
| P/E | No value: no close yet | No value: no price history | |
| EV/Sales | No value: no close yet | No value: no price history | |
| EV/EBITDA | No value: no close yet | No value: no price history | |
| Price/FCF | No value: no close yet | No value: no price history | |
| Market cap | No value: no close yet | ||
| Net debt and other claims(enterprise value minus market cap) | No value: no close yet | ||
| Enterprise value | No value: no close yet |
How the business is doing
| Figure | Last 12 months | 1-year change1-year | Yearly, 3 years | 8 quarters |
|---|---|---|---|---|
| Revenue | $11.6B | +20.5%(better for the company) | +19.1% | Each quarter is listed in the row's details. |
| Diluted EPS | $8.41 | +10.8%(better for the company) | +25.7% | Each quarter is listed in the row's details. |
| Free cash flow | No value: not in the filings | No value: not in the filings | No value: not in the filings | No value: too few quarters |
| Gross margin | 67.2% | +0.8 pp(better for the company) | +0.2 pp | Each quarter is listed in the row's details. |
| Operating margin | 28.4% | −0.9 pp(worse for the company) | +1.2 pp | Each quarter is listed in the row's details. |
| Net margin | 25.5% | −3.0 pp(worse for the company) | +1.1 pp | Each quarter is listed in the row's details. |
| Share count | 351.600M | −2.8%(better for the company) | −0.6% | Each quarter is listed in the row's details. |
How to read these figures
- Last 12 months: the latest four reported quarters added up, or a figure computed from them. The share count is its latest quarter's average.
- 1-year change: the last 12 months against the 12 months a year earlier. A margin's change is in percentage points (pp). On a Next 12 months row, it is Moatsight's estimate against the last 12 months.
- Yearly, 3 years: the yearly rate over the last 3 years, compounded. For a margin, its average change a year in percentage points.
- 8 quarters: the last 12 months at each of the latest 8 quarter ends, oldest on the left; the dot is the latest. The quarters themselves are on Financials.
- n/m: not meaningful, such as a rate of change from a loss.
- Color: a 1-year change in the gain color is better for the company, one in the loss color worse. The caret and the sign show which way it moved, and a row where lower is better says so in its details. Color judges the company's reported results, never its share price or Moatsight's estimates, and no other column is colored.
Price
No closing prices are stored for this listing yet.
Facts
- Exchange
- Nasdaq · USD
- Kind
- Common stock
- Security
- Common Stock